Posted by Michael Wonder on 05 Jun 2017
Top medicines panel benefits from second consumer representative
2 June 2017 - The appointment of a second consumers representative to the Pharmaceutical Benefits Advisory Committee recognises the value of the consumer perspective in vital decisions about access to medicines, the Consumers Health Forum said today.
“We are delighted that Bel Harper has been appointed to the PBAC which recommends to Government which new medicines should receive subsidies,” Leanne Wells, CEO of the Consumers Health Forum, said.
“Ms Harper is a member of the CHF board and brings more than 15 years’ experience in program development, managing not-for-profit organisations and community advocacy.
